To receive information, please complete the form below. All of the fields with (*) must be filled into send the form. All data submitted will only be used for this purpose.

Micromacinazione takes over micronization division of Neo-Micro AG

A novel engineering platform to enhance the dissolution rate of poorly soluble drugs.

Cross acquires a majority stake in Micromacinazione as part of a succession solution.

We are glad to announce that recently (28-30 March 2012) we passed a 3-day FDA inspection successfully at both our manufacturing sites, Molinazzo di Monteggio and Madonna del Piano, without any observation.

Possibility to produce nanoparticles by super- critical fluid precipitation under fully cGMP conditions.